CARM
PINK Carisma Therapeutics, Inc.$0.0005 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0005, and at the day’s high of $0.0005
- YTD change
- -98.84%
- vs 20-day SMA
- -31.97%
- vs 200-day SMA
- -97.51%
Price ranges
Price & Performance
-0.03 (-98.53%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $9.7662
- CARM is down 99% since the beginning of the year
- CARM is down 100% over the past 12 months
- CARM is down 50% over the past 1 month
- 0% of all CARM investors are betting against CARM
CARM reads n/a: price sits below both the 20- and 200-day averages, the 12-month move is -99.8%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- -37.50%
- vs 8-day SMA
- -24.53%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
